ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!NRSN Company Profile and Key Details
NeuroSense Therapeutics Ltd.
NRSN Stock Price Chart
Stock Price Today
NeuroSense Therapeutics Ltd. (NRSN) stock declined over -0.91%, trading at $1.09 on NASDAQ, down from the previous close of $1.10. The stock opened at $1.13, fluctuating between $1.06 and $1.13 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Company Information
| Employees | 18 |
| Beta | 1.25 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) stock price is $1.09 in the last trading session. During the trading session, NRSN stock reached the peak price of $1.13 while $1.06 was the lowest point it dropped to. The percentage change in NRSN stock occurred in the recent session was -0.91% while the dollar amount for the price change in NRSN stock was -$0.01.
The NASDAQ listed NRSN is part of Biotechnology industry that operates in the broader Healthcare sector. NeuroSense Therapeutics Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Shiran Zimri Ph.D.
Head of Scientific Program
Ms. Nedira Salzman-Frenkel
Global Head of Bus. Devel.
Ms. Hagit Binder
Chief Operation Officer
Dr. Ferenc Tracik M.D.
Chief Medical Officer
Ms. Diana Shtossel
Head of Regulatory Affairs
Dr. Niva Russek-Blum Ph.D.
Global Head of Discovery & IP Generator
Dr. Sharon Cohen Vered Ph.D.
Global Head of CMC
Ms. Yael Barak
Vice President of Quality & Compliance
Mr. Alon Ben-Noon
Co-Founder, Chief Executive Officer & Director
Mr. Or Eisenberg
Chief Financial Officer
Ms. Keren Pushett
Head of HR
NRSN's closing price is 112.89% higher than its 52-week low of $0.51 where as its distance from 52-week high of $2.33 is -53.22%.
Number of NRSN employees currently stands at 18.
Official Website of NRSN is: https://www.neurosense-tx.com
NRSN could be contacted at phone 972 979 96183 and can also be accessed through its website. NRSN operates from Building B, Herzliya, 4672562, Israel.
NRSN stock volume for the day was 102.01K shares. The average number of NRSN shares traded daily for last 3 months was 290.43K.
The market value of NRSN currently stands at $25.32M with its latest stock price at $1.09 and 23.23M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com